ReachMD

Episodes 1-15 of 567

• • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Shirish Gadgeel, MD

    Peer

  0

  

  RestartResume

  Checkpoint Inhibitor Combination Therapy for First-Line Advanced NSCLC

  Checkpoint Inhibitor Combination Therapy for First-Line Advanced NSCLC

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Keith McCrae, MD

    Peer

  3

  

  RestartResume

  Key Recommendations for ITP: Updates on Management & Treatment from the 2019 ASH Guidelines

  Key Recommendations for ITP: Updates on Management & Treatment from the 2019 ASH Guidelines

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Stephen Hanauer, MD

    Peer

  0

  

  RestartResume

  Understanding the Evolving Role of Biosimilars in Gastroenterology

  Understanding the Evolving Role of Biosimilars in Gastroenterology

• • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Benjamin Kann, MD

    Peer

  1

  

  RestartResume

  Aiding Decision-Making with Artificial Intelligence

  Aiding Decision-Making with Artificial Intelligence

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Mikkael A. Sekeres, MD, MS

    Peer

  • 

    

    Sara M. Tinsley, PhD, ARNP, AOCNP

    Peer

  2

  

  RestartResume

  A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway

  A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway

  0.50 credits

• • 

    

    Arjun V. Balar, MD

    Peer

  • 

    

    Daniel P. Petrylak, MD

    Peer

  0

  

  RestartResume

  State of the Union: Advances in the Management of mUC

  State of the Union: Advances in the Management of mUC

  0.50 credits

• • 

    

    Jay Raman, MD, FACS

    Peer

  • 

    

    Oguz Akin, MD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  • 

    

    Elizabeth Plimack, MD, MS

    Peer

  0

  

  RestartResume

  RCC Treatment Strategies in a Poor-Risk Patient

  RCC Treatment Strategies in a Poor-Risk Patient

  0.50 credits

• • 

    

    Maria E. Arcila, MD

    Peer

  • 

    

    Alexander Drilon, MD

    Peer

  0

  

  RestartResume

  Practicing Precision in ALK and ROS1 Rearrangement Positive NSCLC: Testing, Targets, and Treatments

  Practicing Precision in ALK and ROS1 Rearrangement Positive NSCLC: Testing, Targets, and Treatments

  1.00 credits

• • 

    

    Jeffrey V. Matous, MD

    Peer

  2

  

  RestartResume

  Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy

  Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy

• • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Brad McGregor, MD

    Peer

  0

  

  RestartResume

  Clearing Up Non-Clear Cell Renal Cell Carcinoma Management

  Clearing Up Non-Clear Cell Renal Cell Carcinoma Management

• • 

    

    Jacob Sands, MD

    Peer

  • 

    

    Derek Raghavan, MD, PhD, FACP, FRACP

    Peer

  1

  

  RestartResume

  Serving the Underserved: The Role of CT Scans in Lung Cancer Screening

  Serving the Underserved: The Role of CT Scans in Lung Cancer Screening

• • 

    

    Ezra Cohen, MD

    Peer

  • 

    

    Barbara Burtness, MD

    Peer

  7

  

  RestartResume

  Updates in Head and Neck Cancer Treatment: Integrating Checkpoint Inhibitor Therapy to Improve Outcomes

  Updates in Head and Neck Cancer Treatment: Integrating Checkpoint Inhibitor Therapy to Improve Outcomes

  0.25 credits

• • 

    

    Tracey Evans, MD

    Peer

  • 

    

    Raja Mudad, MD

    Peer

  1

  

  RestartResume

  An Immunotherapy Combination as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

  An Immunotherapy Combination as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

• • 

    

    Tracey Evans, MD

    Peer

  • 

    

    Raja Mudad, MD

    Peer

  2

  

  RestartResume

  Patient Case Study: A First-Line Treatment Approach in Extensive-Stage Small Cell Lung Cancer

  Patient Case Study: A First-Line Treatment Approach in Extensive-Stage Small Cell Lung Cancer

• • 

    

    Rana McKay, MD

    Peer

  • 

    

    Paul P. Doghramji, MD, FAAFP

    Peer

  0

  

  RestartResume

  Studying Surveillance & Examining Frontline Treatment: A Look at Therapeutic Approaches for Advanced Cell Renal Carcinoma

  Studying Surveillance & Examining Frontline Treatment: A Look at Therapeutic Approaches for Advanced Cell Renal Carcinoma

• 1
• 2
• 3
• …
• 37
• 38
• Next